Crossmark

Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors. A new drug class for the treatment of hypercholesterolemia

Crossref DOI link: https://doi.org/10.1016/j.endien.2017.08.005

Published Print: 2017-08

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Ortega Martínez de Victoria, Emilio
License Information

Text and Data Mining valid from 2017-08-01
More Information

This article is maintained by: Elsevier

Article Title: Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors. A new drug class for the treatment of hypercholesterolemia

Journal Title: Endocrinología, Diabetes y Nutrición (English ed.)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.endien.2017.08.005

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.endinu.2017.04.005

Content Type: article

Copyright: © 2017 SEEN and SED. Published by Elsevier España, S.L.U. All rights reserved.